Nojima, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 29%, Oct-Dec Ordinary Profit Increases by 8%

OXIDE, Net Income Forecast for the Fiscal Year Revised Downward to a Loss

JCR Pharma, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 83%

Nojima, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 29%, Oct-Dec Ordinary Profit Increases by 8%

NIFTY Lifestyle, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 19%

OXIDE, Net Income Forecast for the Fiscal Year Revised Downward to a Loss

JCR Pharma, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 83%

NIHON KOGYO, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 5%

Nippon Fine Chemical, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2%, Oct-Dec Ordinary Profit Decreases by 33%

FUJI OOZX, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 21%, Oct-Dec Ordinary Profit Decreases by 20%

Daito Chemix, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 12%

Consolidated Financial Results for the Nine-month Period Ended December 31, 2025 (Japanese accounting standards)

【Delayed】Notice Regarding Executive Personnel Changes

【Delayed】Notice Regarding Personnel Changes

Notice Concerning Borrowing of Funds (Determination of Interest Rate)

Notice Concerning Execution of Interest Rate Swap Agreement

Notice Regarding Change in Consolidated Subsidiary (Share Transfer) and Recognition of Extraordinary Loss

Notice of revision to consolidated full-year results forecast

Supplementary Explanation Regarding Revision of Full-Year Earnings Forecast and Change in Consolidated Subsidiary (Share Transfer)